John M. Sprague, Chief Financial Officer at T2 Biosystems, Inc. (TTOO), bought 10,000 shares at $0.48 ($5K) on 2022-04-08, disclosed to the SEC on 2022-04-11.
Open-market purchase of $5k TTOO by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TTOO | SELL | 2020-03-03 | $3K | — | Filing → |